JP2018035153A5 - - Google Patents

Download PDF

Info

Publication number
JP2018035153A5
JP2018035153A5 JP2017163690A JP2017163690A JP2018035153A5 JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5 JP 2017163690 A JP2017163690 A JP 2017163690A JP 2017163690 A JP2017163690 A JP 2017163690A JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5
Authority
JP
Japan
Prior art keywords
genus
versus
graft
host disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017163690A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408092B2 (ja
JP2018035153A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018035153A publication Critical patent/JP2018035153A/ja
Publication of JP2018035153A5 publication Critical patent/JP2018035153A5/ja
Application granted granted Critical
Publication of JP6408092B2 publication Critical patent/JP6408092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017163690A 2016-08-29 2017-08-28 糞便微生物叢を含む組成物 Active JP6408092B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016166656 2016-08-29
JP2016166656 2016-08-29

Publications (3)

Publication Number Publication Date
JP2018035153A JP2018035153A (ja) 2018-03-08
JP2018035153A5 true JP2018035153A5 (https=) 2018-05-17
JP6408092B2 JP6408092B2 (ja) 2018-10-17

Family

ID=61565352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017163690A Active JP6408092B2 (ja) 2016-08-29 2017-08-28 糞便微生物叢を含む組成物

Country Status (2)

Country Link
US (2) US20180185421A1 (https=)
JP (1) JP6408092B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062063B1 (fr) * 2017-01-26 2019-04-19 Centre National De La Recherche Scientifique Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
WO2019238969A1 (en) * 2018-06-14 2019-12-19 4D Pharma Research Ltd Compositions comprising bacterial strains
MX2018010105A (es) * 2018-08-21 2020-02-24 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Sistema de estabilización de microbiota intestinal humana.
EP3870691A4 (en) 2018-09-13 2022-09-07 Xbiome Inc. METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL AND INFLAMMATORY DISORDERS
US20220218800A1 (en) * 2019-05-06 2022-07-14 Synthetic Biologics, Inc. Beta-lactamase compositions for treatment of graft versus host disease
JPWO2021106952A1 (https=) * 2019-11-26 2021-06-03
US20230043598A1 (en) * 2019-12-23 2023-02-09 Hengameh Chloe LAURIDSEN Capsule comprising a faecal composition
JP2024037266A (ja) * 2022-09-07 2024-03-19 日本電気株式会社 情報処理装置、情報処理方法、およびプログラム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
WO2005032589A1 (ja) * 2003-10-02 2005-04-14 Japan Science And Technology Agency Ｇｖｈｄの予防及び治療
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN116942833A (zh) * 2011-12-01 2023-10-27 国立大学法人 东京大学 诱导调节性t细胞的增殖或积累的人源细菌
CA2896795A1 (en) * 2012-11-26 2014-05-30 Thomas Julius Borody Compositions for the restoration of a fecal microbiota and methods for making and using them
AU2014239883B2 (en) * 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP2967077A4 (en) * 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
US9795604B2 (en) * 2013-10-25 2017-10-24 Pharmacyclics Llc Methods of treating and preventing graft versus host disease
WO2015061839A1 (en) * 2013-11-04 2015-05-07 Sturm Marian June Cell culture method
CA3254897A1 (en) * 2014-11-25 2026-03-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome

Similar Documents

Publication Publication Date Title
JP2018035153A5 (https=)
JP2015527308A5 (https=)
JP2018100276A5 (https=)
JP2018012698A5 (https=)
JP2019508486A5 (https=)
WO2015134808A3 (en) Probiotic formulations and methods for use
JP2016523252A5 (https=)
JP2019526543A5 (https=)
JP2016529309A5 (https=)
CO6251326A2 (es) Un exopolisacarido
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
RU2018121036A (ru) Комбинированная пре- и пробиотическая композиция
JP2012120528A5 (https=)
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
JP2019104717A5 (https=)
CN110177765A (zh) 一种复合材料及其制备方法及用途
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
JP2017019841A5 (https=)
JP2021535175A5 (https=)
JP2013523758A5 (https=)
JP2020137724A5 (https=)
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
JP2016508368A5 (https=)
JP2018043949A5 (https=)